Monopar Therapeutics Inc (MNPR) — Defensive Interval Ratio
Monopar Therapeutics Inc (MNPR) has a Defensive Interval Ratio of 10 days as of December 2025. Defensive assets of $78.57 Million (cash $-, short-term investments $78.57 Million, receivables $-) cover 10 days of daily cash needs of $7.49 Million/day. Check MNPR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Monopar Therapeutics Inc Defensive Interval Ratio (2021–2025)
This chart shows how Monopar Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 10 days, meaning defensive assets of $78.57 Million can fund 10 days of operations without new revenue. Also explore MNPR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Monopar Therapeutics Inc (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Monopar Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Monopar Therapeutics Inc worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 10 days | $78.57 Million | $7.49 Million/day | $- | $78.57 Million | ▼ -990 days |
| 2024 | 1000 days | $14.40 Million | $14.40K/day | $- | $14.40 Million | ▲ +1000 days |
| 2023 | 0 days | $0.00 | $4.81K/day | $- | $0.00 | ▼ -576 days |
| 2022 | 576 days | $4.93 Million | $8.57K/day | $- | $4.93 Million | ▲ +576 days |
| 2021 | 0 days | $0.00 | $4.33K/day | $- | $0.00 | — |